WellCare Names Timothy Trodden Chief Human Resources Officer

TAMPA, Fla., Jan. 9, 2017 WellCare Health Plans, Inc. (NYSE: WCG) announced today it has named Timothy Trodden senior vice president, chief human resources officer, effective Jan. 9. Trodden is responsible to create and drive an overarching people strategy that supports enterprise-wide priorities. He reports to WellCare's CEO Ken Burdick and serves as a member of the executive leadership team.

"Tim is an experienced human resources leader with a successful track record in organizational strategy and talent development," said Burdick. "I expect him to significantly contribute to our company culture and growth agenda."

"I am excited to join a fast-growing company with a focus on continuously improving the associate experience," said Trodden. "I look forward to working with Ken and the leadership team to attract and retain strong talent with a mission to serve."

Trodden was most recently the head of human resources (HR), corporate enterprise functions for Johnson & Johnson where he led overall HR and talent strategy. He held other HR leadership roles at Johnson & Johnson over his 16 years with the company.

Trodden holds a bachelor's degree from Seton Hall University and a master's degree in human resources management from Rutgers University. He also completed Wharton's Executive Development Program.

About WellCare Health Plans, Inc.

Headquartered in Tampa, Fla., WellCare Health Plans, Inc. (NYSE: WCG) focuses exclusively on providing government-sponsored managed care services, primarily through Medicaid, Medicare Advantage and Medicare Prescription Drug Plans, to families, children, seniors and individuals with complex medical needs. WellCare serves approximately 3.8 million members nationwide as of Sept. 30, 2016. For more information about WellCare, please visit the company's website at www.wellcare.com or view the company's videos at https://www.youtube.com/user/WellCareHealthPlan.

 

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?